ATE447947T1 - Pharmazeutische zubereitungen zur behandlung von insulinresitenz - Google Patents
Pharmazeutische zubereitungen zur behandlung von insulinresitenzInfo
- Publication number
- ATE447947T1 ATE447947T1 AT00945483T AT00945483T ATE447947T1 AT E447947 T1 ATE447947 T1 AT E447947T1 AT 00945483 T AT00945483 T AT 00945483T AT 00945483 T AT00945483 T AT 00945483T AT E447947 T1 ATE447947 T1 AT E447947T1
- Authority
- AT
- Austria
- Prior art keywords
- insulinresience
- treatment
- pharmaceutical preparations
- preparations
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14240799P | 1999-07-06 | 1999-07-06 | |
PCT/CA2000/000798 WO2001001969A2 (en) | 1999-07-06 | 2000-07-05 | Methods of treating and/or suppressing weight gain |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE447947T1 true ATE447947T1 (de) | 2009-11-15 |
Family
ID=22499734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00945483T ATE447947T1 (de) | 1999-07-06 | 2000-07-05 | Pharmazeutische zubereitungen zur behandlung von insulinresitenz |
Country Status (25)
Country | Link |
---|---|
US (2) | US6710059B1 (de) |
EP (1) | EP1196163B1 (de) |
JP (1) | JP4790178B2 (de) |
KR (1) | KR101141763B1 (de) |
CN (1) | CN1390126B (de) |
AR (1) | AR034091A1 (de) |
AT (1) | ATE447947T1 (de) |
AU (3) | AU5957500A (de) |
BR (1) | BR0012354A (de) |
CA (1) | CA2376158C (de) |
DE (1) | DE60043305D1 (de) |
DK (1) | DK1196163T3 (de) |
HK (1) | HK1046240B (de) |
HU (1) | HU230543B1 (de) |
IL (2) | IL147485A0 (de) |
MX (1) | MX270786B (de) |
MY (1) | MY134574A (de) |
NO (1) | NO329614B1 (de) |
NZ (1) | NZ516453A (de) |
PL (1) | PL208972B1 (de) |
RU (3) | RU2327461C2 (de) |
TR (2) | TR200403328T2 (de) |
TW (1) | TWI359015B (de) |
WO (1) | WO2001001969A2 (de) |
ZA (1) | ZA200200085B (de) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7005428B1 (en) * | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
NZ536787A (en) * | 1998-06-11 | 2006-03-31 | Endorech Inc | Pharmaceutical compositions and uses for androst-5-ene-3beta,17beta diol |
US6465445B1 (en) * | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
US6560217B1 (en) | 1999-02-25 | 2003-05-06 | 3Com Corporation | Virtual home agent service using software-replicated home agents |
TR200403328T2 (tr) * | 1999-07-06 | 2005-03-21 | Endorecherche, Inc. | Kilo alımını tedavi ve/veya önleme metotları. |
AU7896100A (en) * | 1999-10-14 | 2001-04-23 | Endorecherche Inc. | Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance |
WO2001054699A1 (en) * | 2000-01-28 | 2001-08-02 | Endorecherche, Inc. | Selective estrogen receptor modulators in combination with estrogens |
CA2461142A1 (en) * | 2001-09-24 | 2003-04-03 | Bayer Pharmaceuticals Corporation | Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity |
NZ534757A (en) | 2002-03-12 | 2006-07-28 | Merck & Co Inc | Substituted amides |
WO2004054573A1 (en) * | 2002-12-13 | 2004-07-01 | N.V. Nutricia | Method and composition for inhibiting carbohydrate digestion |
US7074779B2 (en) | 2003-07-02 | 2006-07-11 | Ortho-Mcneil Pharmaceutical, Inc. | Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors |
CN106038572A (zh) | 2004-10-20 | 2016-10-26 | 恩多研究公司 | 性甾体前体单独或与选择性雌激素受体调节剂联合用于预防和治疗绝经后女性的性功能障碍 |
US20060234993A1 (en) * | 2005-04-13 | 2006-10-19 | Eric Marchewitz | Use of androstane derivatives for enhancing physical performance |
US20070009564A1 (en) * | 2005-06-22 | 2007-01-11 | Mcclain James B | Drug/polymer composite materials and methods of making the same |
PE20070188A1 (es) * | 2005-06-29 | 2007-03-16 | Wyeth Corp | Formulaciones de estrogenos conjugados y bazedoxifeno |
US20090062909A1 (en) * | 2005-07-15 | 2009-03-05 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
ES2691646T3 (es) | 2005-07-15 | 2018-11-28 | Micell Technologies, Inc. | Revestimientos poliméricos que contienen polvo de fármaco de morfología controlada |
EP2944382A1 (de) * | 2006-04-26 | 2015-11-18 | Micell Technologies, Inc. | Beschichtungen mit mehreren wirkstoffen |
WO2008042909A2 (en) | 2006-10-02 | 2008-04-10 | Micell Technologies Inc. | Surgical sutures having increased strength |
CA2667228C (en) * | 2006-10-23 | 2015-07-14 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
CN101711137B (zh) | 2007-01-08 | 2014-10-22 | 米歇尔技术公司 | 具有可生物降解层的支架 |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
BRPI0810370A2 (pt) * | 2007-04-17 | 2014-10-29 | Micell Technologies Inc | Stent revestido, e, método para preparar um stent |
CA2688314C (en) * | 2007-05-25 | 2013-12-03 | Micell Technologies, Inc. | Polymer films for medical device coating |
US8268806B2 (en) | 2007-08-10 | 2012-09-18 | Endorecherche, Inc. | Pharmaceutical compositions |
WO2009051780A1 (en) * | 2007-10-19 | 2009-04-23 | Micell Technologies, Inc. | Drug coated stents |
EP2271294B1 (de) * | 2008-04-17 | 2018-03-28 | Micell Technologies, Inc. | Stents mit biologisch abbaubaren schichten |
AU2009270849B2 (en) * | 2008-07-17 | 2013-11-21 | Micell Technologies, Inc. | Drug delivery medical device |
US9510856B2 (en) | 2008-07-17 | 2016-12-06 | Micell Technologies, Inc. | Drug delivery medical device |
US8834913B2 (en) * | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
WO2010111232A2 (en) * | 2009-03-23 | 2010-09-30 | Micell Technologies, Inc. | Drug delivery medical device |
CA2756307C (en) * | 2009-03-23 | 2017-08-08 | Micell Technologies, Inc. | Peripheral stents having layers and reinforcement fibers |
CA2756388C (en) * | 2009-03-23 | 2015-10-27 | Micell Technologies, Inc. | Biodegradable polymers with low acidic impurity |
WO2010120552A2 (en) * | 2009-04-01 | 2010-10-21 | Micell Technologies, Inc. | Coated stents |
WO2010121187A2 (en) | 2009-04-17 | 2010-10-21 | Micell Techologies, Inc. | Stents having controlled elution |
US20100317635A1 (en) | 2009-06-16 | 2010-12-16 | Endorecherche, Inc. | Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators |
AU2014201406B2 (en) * | 2009-06-16 | 2016-08-11 | Endorecherche, Inc. | Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators |
WO2011007882A1 (ja) * | 2009-07-16 | 2011-01-20 | 国立大学法人九州大学 | インスリン産生細胞誘導剤、グルコース取込み促進剤および糖尿病または糖尿病合併症の治療薬 |
US11369498B2 (en) | 2010-02-02 | 2022-06-28 | MT Acquisition Holdings LLC | Stent and stent delivery system with improved deliverability |
US8795762B2 (en) * | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
US10232092B2 (en) | 2010-04-22 | 2019-03-19 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
ES2627692T3 (es) | 2010-06-10 | 2017-07-31 | Aragon Pharmaceuticals, Inc. | Moduladores de receptores de estrógenos y usos de los mismos |
KR20150039882A (ko) | 2010-06-16 | 2015-04-13 | 앙도르쉐르슈 인코포레이티드 | 에스트로겐-관련 질병의 치료 또는 예방 방법 |
CA2805631C (en) | 2010-07-16 | 2018-07-31 | Micell Technologies, Inc. | Drug delivery medical device |
WO2012166819A1 (en) | 2011-05-31 | 2012-12-06 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
CA2841360A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
CA2857057A1 (en) | 2011-12-14 | 2013-06-20 | Seragon Pharmaceuticals, Inc. | Fluorinated estrogen receptor modulators and uses thereof |
CA2857061A1 (en) | 2011-12-16 | 2013-06-20 | Olema Pharmaceuticals, Inc. | Novel benzopyran compounds, compositions and uses thereof |
US11039943B2 (en) | 2013-03-12 | 2021-06-22 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
JP2016519965A (ja) | 2013-05-15 | 2016-07-11 | マイセル・テクノロジーズ,インコーポレイテッド | 生体吸収性バイオメディカルインプラント |
US9744177B2 (en) * | 2014-03-10 | 2017-08-29 | Endorecherche, Inc. | Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM |
US10398689B2 (en) * | 2015-12-22 | 2019-09-03 | Jiangsu Hengrui Medicine Co., Ltd. | Benzopiperidine derivative, preparation method thereof and medical use thereof |
US20180207177A1 (en) * | 2017-01-23 | 2018-07-26 | Government Of The United States As Represented By The Secretary Of The Air Force | TREATMENT OF TRIPLE NEGATIVE BREAST CANCER UTILIZING ANDROST-5-ENE-3b,17b-DIOL (b-AED), ANDROST-5-ENE-3b,7b,17b-TRIOL (b-AET) AND ESTRADIOL (E2) |
CN114315851B (zh) * | 2022-01-03 | 2023-10-24 | 安徽大学绿色产业创新研究院 | 一种光甘草定药物中间体的合成方法 |
JP7440838B1 (ja) | 2023-07-06 | 2024-02-29 | 株式会社インタートレードヘルスケア | 卵巣機能欠落生体の内臓脂肪蓄積抑制飲食品、及び卵巣機能欠落生体の内臓脂肪蓄積抑制薬 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2504119B1 (fr) * | 1981-04-17 | 1985-09-20 | Aury Jean Pierre | Beton isolant ainsi que son procede de fabrication |
DE3117979A1 (de) * | 1981-05-07 | 1983-01-20 | Hoechst Ag, 6000 Frankfurt | Neue(delta)1-pyrrolin-thiolactimaether und verfahren zu ihrer herstellung |
US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
US5254568A (en) * | 1990-08-09 | 1993-10-19 | Council Of Scientific & Industrial Research | Benzopyrans as antiestrogenic agents |
US6060503A (en) * | 1991-12-02 | 2000-05-09 | Endorecherche, Inc. | Benzopyran-containing compounds and method for their use |
TW366342B (en) | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
ZA944377B (en) | 1993-06-24 | 1995-12-20 | Lilly Co Eli | Hypoglycemic agents |
US5446061A (en) * | 1993-11-05 | 1995-08-29 | Eli Lilly And Company | Methods for lowering serum cholesterol |
US5527788A (en) * | 1994-01-18 | 1996-06-18 | Louisiana State Univ. Medical Center Foundation | Method and composition for treating obesity comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent |
US5441986A (en) * | 1994-07-19 | 1995-08-15 | Pfizer Inc. | Estrogen agonists as remedies for prostate and cardiovascular diseases |
US5552412A (en) * | 1995-01-09 | 1996-09-03 | Pfizer Inc | 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis |
ZA965346B (en) * | 1995-06-30 | 1997-12-24 | Lilly Co Eli | Methods of treating neuropeptide Y-associated conditions. |
IL120266A (en) * | 1996-02-28 | 2005-05-17 | Pfizer | Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions |
US5843984A (en) * | 1996-05-09 | 1998-12-01 | Eli Lilly And Company | Sulfated benzothiophene derivatives, methods of use and formulations containing same |
WO1999002512A1 (en) * | 1997-07-09 | 1999-01-21 | Novo Nordisk A/S | Dl-2,3-diaryl-2h-1-benzopyrans |
AU8433898A (en) * | 1997-07-10 | 1999-02-08 | Novo Nordisk A/S | Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for increasing insulin sensitivity |
NZ502738A (en) * | 1997-08-15 | 2002-06-28 | Univ Duke | Triphenylethylene derivatives similar to tamoxifen or toremifene derivatives |
EP1021191B1 (de) * | 1997-10-08 | 2002-06-05 | Genesiscosmetics Rights & Licenses Company Limited | Straffung und/oder verkleinerung von fettzellen-haltigen körperpartien |
CZ299334B6 (cs) | 1998-05-15 | 2008-06-25 | Wyeth | Farmaceutický prostredek |
US6465445B1 (en) * | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
US7005428B1 (en) * | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
NZ536787A (en) | 1998-06-11 | 2006-03-31 | Endorech Inc | Pharmaceutical compositions and uses for androst-5-ene-3beta,17beta diol |
AU771352B2 (en) * | 1999-06-18 | 2004-03-18 | Stephen James Cordell | Finishing tool |
TR200403328T2 (tr) * | 1999-07-06 | 2005-03-21 | Endorecherche, Inc. | Kilo alımını tedavi ve/veya önleme metotları. |
-
2000
- 2000-07-05 TR TR2004/03328T patent/TR200403328T2/xx unknown
- 2000-07-05 JP JP2001507463A patent/JP4790178B2/ja not_active Expired - Lifetime
- 2000-07-05 DE DE60043305T patent/DE60043305D1/de not_active Expired - Lifetime
- 2000-07-05 TW TW096104627A patent/TWI359015B/zh not_active IP Right Cessation
- 2000-07-05 IL IL14748500A patent/IL147485A0/xx active IP Right Grant
- 2000-07-05 MX MXPA02000075 patent/MX270786B/es unknown
- 2000-07-05 WO PCT/CA2000/000798 patent/WO2001001969A2/en active Application Filing
- 2000-07-05 CA CA2376158A patent/CA2376158C/en not_active Expired - Lifetime
- 2000-07-05 AT AT00945483T patent/ATE447947T1/de not_active IP Right Cessation
- 2000-07-05 HU HU0202363A patent/HU230543B1/hu unknown
- 2000-07-05 CN CN008124744A patent/CN1390126B/zh not_active Expired - Lifetime
- 2000-07-05 DK DK00945483.6T patent/DK1196163T3/da active
- 2000-07-05 RU RU2002102914/15A patent/RU2327461C2/ru active
- 2000-07-05 EP EP00945483A patent/EP1196163B1/de not_active Expired - Lifetime
- 2000-07-05 NZ NZ516453A patent/NZ516453A/en unknown
- 2000-07-05 KR KR1020027000177A patent/KR101141763B1/ko active IP Right Grant
- 2000-07-05 PL PL352993A patent/PL208972B1/pl unknown
- 2000-07-05 TR TR2005/02284T patent/TR200502284T2/xx unknown
- 2000-07-05 BR BR0012354-4A patent/BR0012354A/pt not_active Application Discontinuation
- 2000-07-05 AU AU59575/00A patent/AU5957500A/en not_active Abandoned
- 2000-07-06 AR ARP000103450A patent/AR034091A1/es not_active Application Discontinuation
- 2000-07-06 MY MYPI20003087A patent/MY134574A/en unknown
- 2000-07-06 US US09/610,286 patent/US6710059B1/en not_active Expired - Lifetime
-
2002
- 2002-01-04 ZA ZA200200085A patent/ZA200200085B/xx unknown
- 2002-01-04 NO NO20020037A patent/NO329614B1/no not_active IP Right Cessation
- 2002-10-17 HK HK02107552.3A patent/HK1046240B/zh unknown
-
2003
- 2003-03-10 US US10/387,043 patent/US8609695B2/en not_active Expired - Fee Related
-
2005
- 2005-11-04 AU AU2005229713A patent/AU2005229713A1/en not_active Abandoned
-
2008
- 2008-01-16 RU RU2008101793/15A patent/RU2519642C2/ru active
- 2008-12-11 IL IL195860A patent/IL195860A/en active IP Right Grant
-
2009
- 2009-01-23 AU AU2009200258A patent/AU2009200258B2/en not_active Expired
-
2013
- 2013-10-30 RU RU2013148518A patent/RU2636498C2/ru active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE447947T1 (de) | Pharmazeutische zubereitungen zur behandlung von insulinresitenz | |
DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
DE69929996D1 (de) | Pharmazeutisches mittel zur behandlung von diabetes | |
ATE308997T1 (de) | Mittel zur behandlung von erkrankungen der speiseröhre | |
DE50206657D1 (de) | Pharmazeutische zusammensetzung zur behandlung von multiple sklerose | |
DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
DE69710095T2 (de) | Pharmazeutische zubereitung zur behandlung von diabetes | |
DE60142473D1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
DK0956858T3 (da) | Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner | |
ATE275145T1 (de) | Chinazolinderivate zur behandlung von tumoren | |
DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
DE60126321D1 (de) | Gelsystem zur ocularen verabreichung von arzneimitteln | |
DE60239648D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Asthma | |
ATE269303T1 (de) | Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen | |
ATE384522T1 (de) | Medikamente zur chemotherapeutischen behandlung von erkrankungen | |
DE50010284D1 (de) | Arzneimittel zur behandlung von bluthochdruck | |
DE60027209D1 (de) | Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen | |
DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
DE69420229T2 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
ATE247466T1 (de) | Pharmazeutische zubereitungen enthaltend ibuprofen und domperidon zur behandlung von migräne | |
DE69916488D1 (de) | Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren | |
ATE299371T1 (de) | Antikonvulsiva zur behandlung von autismus | |
DE60006412D1 (de) | Oxazinochinolone zur behandlung von viralen infektionen | |
NO20020784L (no) | Medikament for behandling av brudd |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |